There were 1,553 press releases posted in the last 24 hours and 398,379 in the last 365 days.

EXOCEL BIO'S GROUNDBREAKING STUDY PUBLISHED IN THE JOURNAL OF DRUGS IN DERMATOLOGY

ExocelBio

ExoCel Bio Product Line

Exosomes Found To Have A Positive Affect Wound Healing

DOYLESTOWN, PENNSYLVANIA , UNITED STATES, October 12, 2023 /EINPresswire.com/ -- ExoCel Bio, the premier manufacturer of medical grade, fully lab-tested and non-lyophilized pure exosomes, is proud to announce their study on exosomes and wound healing has been published in the Journal of Drugs in Dermatology.

The study, conducted by Dr. Marina Peredo, a board-certified dermatologist, and Dr. Shanthala Shivananjappa, presents a series of cases where patients were treated with exosomes after an aesthetic treatment or traumatic injury. Specifically, the doctors applied Exocel Bio’s Exovex™ serum topically to patients post fractional non-ablative laser treatment, to a patient who suffered a dog bite, and made a comparison with PRP treatments.

“These findings are invaluable to the progression of exosome treatments aesthetically and in wound healing,” says the Chief Medical Officer of ExoCel Bio, Dr. Roger Schechter. “It shows how exosomes are able to alleviate pain, scarring and more. We are thrilled to share our findings in the Journal of Drugs in Dermatology.”

It was found that exosomes rapidly and dramatically accelerated recovery times for these patients with no adverse effects. For aesthetic treatments, exosomes provided minimal downtime and with post-surgical scarring, wound healing was sped up significantly.

The full study can be found online at https://jddonline.com. The study is also being published in the December 2023 issue of the Journal of Drugs in Dermatology. Exovex™ is currently deployed to over 500 providers. To learn more, or find a provider, visit www.exocelbio.com

About ExoCel Bio™ :
Leveraging nanoparticle technology, Exocel Bio™ has dedicated years of research to develop innovative, natural products that contain exosomes to deliver the highest performing topical serums on the market. Exovex™ products are designed to be applied to the skin in conjunction with facial, microneedling, energy based aesthetic devices, and other medical grade skin treatments, to accelerate recovery time and enhance treatment results. Exovex™ acts synergistically with medical aesthetic interventions to help alleviate skin discoloration, enhance tone and texture, as well as reducing the appearance of fine lines. To learn more visit www.exocelbio.com

###

Contact: FGPR exocelbio@foxgreenberg.com

Alexa Gould
Fox Greenberg Public Relations
+1 914-523-8511
email us here
Visit us on social media:
Facebook
LinkedIn
Instagram
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.